<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02811536</url>
  </required_header>
  <id_info>
    <org_study_id>OCTA Bern</org_study_id>
    <nct_id>NCT02811536</nct_id>
  </id_info>
  <brief_title>Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)</brief_title>
  <official_title>Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that
      employs motion contrast imaging to high-resolution volumetric blood flow information. OCTA
      compares the decorrelation signal between sequential OCT b-scans taken at precisely the same
      cross-section in order to construct a map of blood flow. At present, level 1 evidence of the
      technology's clinical applications doesn't exist. The investigators plan to compare OCTA as
      an imaging modality to conventional imaging modalities used in clinical routine.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the sensitivity and specificity of OCTA</measure>
    <time_frame>2 years</time_frame>
    <description>The primary objective of this observational study is to evaluate the sensitivity and specificity to diagnose vascular abnormalities with OCTA compared to conventional imaging methods. The main parameter that will be assessed is area of nonperfusion of the retina. The incidence (binary) of nonperfusion areas will be assessed in OCTA and compared to conventional imaging methods such as fluorescein angiography.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the intra-and inter-reader reproducibility of the diagnosis of vascular abnormalities using OCTA</measure>
    <time_frame>2 years</time_frame>
    <description>The primary objective of this observational study is to evaluate the sensitivity and specificity to diagnose vascular abnormalities with OCTA compared to conventional imaging methods. The main parameter that will be assessed is area of nonperfusion of the retina. The incidence (binary) of nonperfusion areas will be assessed in OCTA and compared to conventional imaging methods such as fluorescein angiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCTA and Fundus color photographs</measure>
    <time_frame>2 years</time_frame>
    <description>Evaluation whether pathological changes seen in OCT or color fundus photography correlate with changes seen in OCTA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subgroup analysis</measure>
    <time_frame>2 years</time_frame>
    <description>Subgroup analysis will be performed with patients suffering from diabetic retinopathy, artery occlusion, carotid stenosis, retinal detachment, vein occlusion, age related macular degeneration, retinal changes from arterial hypertension, retinal macroaneurysms and uveitis.</description>
  </secondary_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Retinal Disease</condition>
  <arm_group>
    <arm_group_label>Diabetic retinopathy</arm_group_label>
    <description>Patients with various degrees of diabetic retinopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinal detachment</arm_group_label>
    <description>Patients with a history of retinal detachment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retinal vein occlusion</arm_group_label>
    <description>Patients with a history of retinal vein occlusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arterial hypertension</arm_group_label>
    <description>Patients with a history of arterial hypertension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carotid artery occlusion</arm_group_label>
    <description>Patients with a history of carotid artery occlusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Age related macular degeneration</arm_group_label>
    <description>Patients with a history of Age related macular degeneration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Macroaneurysms</arm_group_label>
    <description>Patients with a history of retinal macroaneurysms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Central serous chorioretinopathy</arm_group_label>
    <description>Patients with a history of central serous chorioretinopathy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optical coherence tomography angiography</intervention_name>
    <description>Imaging with optical coherence tomography angiography</description>
    <arm_group_label>Diabetic retinopathy</arm_group_label>
    <arm_group_label>Retinal detachment</arm_group_label>
    <arm_group_label>Retinal vein occlusion</arm_group_label>
    <arm_group_label>Arterial hypertension</arm_group_label>
    <arm_group_label>Carotid artery occlusion</arm_group_label>
    <arm_group_label>Age related macular degeneration</arm_group_label>
    <arm_group_label>Macroaneurysms</arm_group_label>
    <arm_group_label>Central serous chorioretinopathy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with a history of clinically diagnosed retinal diseases, including but not
        limited to age-related macular degeneration, diabetic retinopathy, retinal vein occlusion,
        macular macroaneurysma, and diabetic macular edema and healthy individuals undergoing
        ophthalmic Imaging in Routine clinical practice will be included
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        Patients from the Department of Ophthalmology, University Hospital Bern requiring
        conventional imaging for eye disease and willing to sign informed consent Patients of 18
        years or older

        Exclusion criteria:

        Patients not willing or able to sign informed consent Patients younger than 18 years
        Patients with epilepsy Patients having had photodynamic therapy within the last 48 hours
        prior to imaging with OCTA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Martin S ZINKERNAGEL, MD, PhD</last_name>
    <phone>+41316329565</phone>
    <email>martin.zinkernagel@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Corinne Stöckli</last_name>
    <phone>+41316329565</phone>
    <email>corinne.stöckli@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Inselspital Bern, Department of Ophthalmology</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Zinkernagel, MD, PhD</last_name>
      <phone>+41316329565</phone>
      <email>martin.zinkernagel@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Corinne Stöckli</last_name>
      <phone>+41316321197</phone>
      <email>corinne.stoeckli@insel.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2016</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

